The million-dollar question
Is personalised direct to consumer healthcare a threat or an opportunity for the pharma establishment?
16th December 2020
Web Exclusives
AMR – the fight continues
A new wave of innovation is tackling antibiotic resistance
15th December 2020
Pharma's growing reliance on robotics and automation
How robots will help shape the look of the pharmaceutical industry in 2021
15th December 2020
Should I stay or should I go?
How can pharma help drive COVID-19 vaccination adherence?
10th December 2020
Beyond serialisation
Beyond serialisation – the use of on-dose authentication to protect patients and brands from the rising threat of counterfeit drugs
10th December 2020
The COVID vaccines safety net
The need to implement rigorous post-authorisation monitoring programmes as an added safety net for COVID-19 vaccines
1st December 2020
Working together
Why combining expertise from the NHS and pharmaceutical experts will deliver better patient outcomes
30th November 2020
Pharmacovigilance in a pandemic world
Infusing automation into pharmacovigilance for COVID-19 treatments
10th November 2020
Creative med affairs and bridging the healthcare gap
Med affairs will need to take an increasingly significant role when it comes to engaging with patients and HCPs to unlock the full potential of healthcare, and creativity is the key
6th November 2020
Embracing digitalisation
Five golden rules for pharma businesses to power sales from digital and e-commerce platforms
5th November 2020
Rethinking cancer detection
Research on early cancer detection has been hamstrung by market failure. We’ve got a plan to fix it.
7th October 2020
Breaking borders
How society’s changing relationship with health will break down the wall between pharma brands and consumers
2nd October 2020
